Huntington's Disease Treatment Market Driven by Gene Therapies

Introduction

• Research Objective
• Scope of the Study
• Definition and Taxonomy

Research Methodology

• Research Approach
• Data Sources
• Assumptions

Executive Summary

• Synopsis
• Analyst Recommendations

Market Overview 

• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Value Chain Analysis
  • Raw Material Sourcing
  • Manufacturing Process
  • Logistics & Transportation
  • Buyer Preferences
• Trends
  • Market Trends
  • Technological Trends
• Porter’s Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of Substitute
  • Threat of New Entrants
  • Degree of Competition
• PESTLE Analysis for 5 Leading Countries
  
  • Regulatory Framework for Leading Countries/Regions
  • Supply Demand Analysis
  • Production & Consumption Statistics
  • Export Import Statistics
  • Price Trend Analysis

Global Huntington's Disease Treatment Market Assessment

• Overview
• Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others
• Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

North America Huntington's Disease Treatment Market Assessment

• Overview
• North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others

Europe Huntington's Disease Treatment Market Assessment

• Overview
• Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others

Asia-Pacific Huntington's Disease Treatment Market Assessment

• Overview
• Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others

Latin America Huntington's Disease Treatment Market Assessment

• Overview
• Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others

The Middle East and Africa Huntington's Disease Treatment Market Assessment

• Overview
• The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
  • Diagnostic Imaging
  • Genetic Testing
  • Others
• The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
  • Tetrabenazine
  • Deutetrabenazine
  • Other Drugs
• The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
  • Symptomatic Therapy
  • Disease-Modifying Therapy
  • Others

Company Profiles

• Apitex Inc.
  • Company Overview
  • Geographic Footprints
  • Financial Performance
  • Product Portfolio
  • SWOT Analysis
  • R&D Efforts
  • Recent Developments & Strategic Collaborations
    • Product Launch/M&A/Technical Collaboration
• Teva Pharmaceuticals Industries
• Athena Diagnostic
• Alnylam Pharmaceuticals
• Elekta AB
• Pfizer Inc.
• SOM BIOTECH
• Armata Pharmaceuticals, Inc.
• H. Lundbeck A/S
• Fulgent Genetics

Conclusion & Recommendations